Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03027427 · ClinicalTrials.gov registry record
Prospective Evaluation and Molecular Profiling in People With Gastric Tumors
A clinical trial of Stomach Cancer and Stomach Neoplasms, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- 109
- Enrollment target
- 1
- Study location
NCT03027427: Completed study of Stomach Cancer and Stomach Neoplasms, sponsored by National Cancer Institute (NCI).
NCT03027427 is a study of Stomach Cancer and Stomach Neoplasms that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 109 participants, below the 628-participant average among 15 other Stomach Cancer trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03027427, a study of Stomach Cancer and Stomach Neoplasms, has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- 109 participants
- Enrollment target
- 1
- Study location
Study Summary
Background: Certain stomach cancers are rare, but they have high mortality rates. Researchers want to learn more about gastric (stomach) tumors. In this study, they want to collect data from people who have stomach cancer or are at risk to get it. This data will be used to see if the people can be in other studies. Objective: To study tissue from stomach tumors and find people eligible for more studies on gastric cancer. Eligibility: Age greater than or equal to 2 years old who have or may have stomach cancer, lesions that may be related to stomach cancer, or an inherited disorder that leads to stomach cancer. Design: Participants will be screened with: Medical history Physical exam Blood and urine tests Heart tests Scans or ultrasound. For the scans, participants lie in a machine that takes pictures. For some scans, they will swallow or be injected with a small amount of radioactive material. Special cameras will show the material in the body. Tumor sample taken with a needle or surgery Some participants will have an endoscopy. A long, flexible tube with a camera will be inserted through the mouth into the stomach. The tube will collect tissue from the stomach. Some participants may have follow-up visits. Some may be invited to join other studies. Others will be contacted by phone to see how they are doing. ...
Primary Outcome
long-term follow up of patients with gastric tumors, or heritable gastric malignancy syndromes screened on this study, to support clinical and preclinical research particularly related to molecular alterations in gastric tumors and their response to therapy
Conditions Studied
Study Locations (1)
Maryland
- National Institutes of Health Clinical Center - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 109 participants |
| Start Date | 2017-02-01 |
| Est. Completion | 2024-11-06 |
What the finished NCT03027427 record still lists
NCT03027427 is an observational study that tracks outcomes without assigning an intervention. The registered 109 participants enrollment target is mid-sized for trials with a published cap, below the 628-participant average among 15 other Stomach Cancer trials with a reported enrollment target (83% lower).
The record links to 2 conditions, with Stomach Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT03027427 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT03027427 about?
NCT03027427 is a clinical study titled "Prospective Evaluation and Molecular Profiling in People With Gastric Tumors". Background: Certain stomach cancers are rare, but they have high mortality rates. Researchers want to learn more about gastric (stomach) tumors. In this study, they want to collect data from people who have stomach cancer or are at risk to get it. This data will be used to see if the people can be ...
What is the current status of trial NCT03027427?
This trial is currently completed. The enrollment target is 109 participants. The study started on 2017-02-01. Estimated completion is 2024-11-06.
What conditions does trial NCT03027427 study?
This clinical trial studies the following conditions: Stomach Cancer, Stomach Neoplasms.
Who is sponsoring clinical trial NCT03027427?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03027427 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stomach Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03027427's enrollment target sits among peer trials
109 5th of 15 higher than 11 of 15 other Stomach Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Stomach Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ivonescimab in Comb. With FOLFOX in Advanced HER2 Neg. GEA
RECRUITING · Phase 2
-
Brodalumab in the Treatment of Immune-Related Adverse Events
RECRUITING · Phase 1
-
Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes
RECRUITING · NA
-
Avutometinib and Defactinib in Diffuse Gastric Cancer
RECRUITING · Phase 2
-
EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer.
RECRUITING · NA
-
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02421380 · 109 participants · NA
Characterization of Hyperpolarized Pyruvate MRI Reproducibility
- NCT04526600 · 109 participants · NA
Fidgeting and Attentional and Emotional Regulation in ADHD
- NCT04835584 · 109 participants · Phase 1
KRT-232 and TKI Study in Chronic Myeloid Leukemia
- NCT06626516 · 109 participants · Phase 1
Tebentafusp-tebn With LDT in Metastatic UM
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI